PENBUTOLOL - NEW NON-SELECTIVE BETA-ADRENERGIC BLOCKING COMPOUND IN TREATMENT OF HYPERTENSION - COMPARISON WITH PROPANOLOL

  • 1 January 1978
    • journal article
    • research article
    • Vol. 10  (2) , 105-106
Abstract
The antihypertensive effect of a new non-selective .beta.-adrenergic blocking compound, penbutolol (40 mg twice daily), was compared with propranolol (160 mg twice daily) in 20 hypertensive patients using a double-blind cross-over scheme. Both compounds reduced both the supine and the standing blood pressure significantly. The magnitude of the responses did not differ significantly and both compounds evoked a commensurate decrease in heart rate. No significant side-effects were noted and laboratory tests did not disclose any biochemical changes.

This publication has 0 references indexed in Scilit: